Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diagnostics
MedTech
Qiagen 'open for discussion' on shareholder value
Qiagen’s outgoing chief executive told investors the company does not “comment on rumors” as takeover talks swirl around the diagnostics specialist.
Ben Adams
Feb 6, 2026 9:15am
Optellum tapped by NHS for AI-powered lung cancer diagnostic
Feb 2, 2026 8:55am
Roche diagnostics biz nudges up 2% amid China drag
Jan 29, 2026 8:45am
TD Cowen picks top 3 medtech prospects from across its portfolio
Jan 27, 2026 11:09am
Reveal Genomics unveils triumvirate of new roles for co-founders
Jan 27, 2026 8:50am
Guardant Health gets FDA nod to expand test for colon cancer
Jan 26, 2026 8:15am
